Investigational Drug Information for Nelotanserin
✉ Email this page to a colleague
What is the drug development status for Nelotanserin?
Nelotanserin is an investigational drug.
There have been 3 clinical trials for Nelotanserin.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2015.
The most common disease conditions in clinical trials are Dementia, Lewy Body Disease, and Hallucinations. The leading clinical trial sponsors are Axovant Sciences Ltd. and [disabled in preview].
Summary for Nelotanserin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 224 |
| WIPO Patent Applications | 94 |
| Japanese Patent Applications | 66 |
| Clinical Trial Progress | Phase 2 (2015-12-01) |
| Vendors | 0 |
Recent Clinical Trials for Nelotanserin
| Title | Sponsor | Phase |
|---|---|---|
| Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder | Axovant Sciences Ltd. | Phase 2 |
| Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD) | Axovant Sciences Ltd. | Phase 2 |
| Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia | Axovant Sciences Ltd. | Phase 2 |
Clinical Trial Summary for Nelotanserin
Top disease conditions for Nelotanserin
Top clinical trial sponsors for Nelotanserin
US Patents for Nelotanserin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
